End-of-day quote
Dhaka S.E.
06:00:00 2024-04-24 pm EDT
|
5-day change
|
1st Jan Change
|
2,413
BDT
|
-0.75%
|
|
-0.70%
|
-1.93%
|
Fiscal Period: March |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
45,259
|
49,219
|
65,426
|
74,189
|
76,277
|
76,013
|
-
|
-
|
Enterprise Value (EV)
1 |
45,259
|
49,219
|
65,426
|
73,812
|
74,152
|
76,013
|
76,013
|
76,013
|
P/E ratio
|
-
|
-
|
-
|
20.9
x
|
19.7
x
|
16.7
x
|
14.9
x
|
13.3
x
|
Yield
|
4.52%
|
6.08%
|
4.33%
|
3.4%
|
3.1%
|
3.33%
|
5.52%
|
7.48%
|
Capitalization / Revenue
|
5.16
x
|
5.02
x
|
5.79
x
|
5.69
x
|
5.4
x
|
5.19
x
|
4.56
x
|
4.08
x
|
EV / Revenue
|
5.16
x
|
5.02
x
|
5.79
x
|
5.69
x
|
5.4
x
|
5.19
x
|
4.56
x
|
4.08
x
|
EV / EBITDA
|
16.9
x
|
14
x
|
14.9
x
|
15.3
x
|
14.3
x
|
12.5
x
|
11.4
x
|
10.2
x
|
EV / FCF
|
17.1
x
|
18.3
x
|
21.4
x
|
22.5
x
|
15.6
x
|
25.8
x
|
16.8
x
|
14.3
x
|
FCF Yield
|
5.83%
|
5.47%
|
4.68%
|
4.44%
|
6.39%
|
3.88%
|
5.96%
|
6.99%
|
Price to Book
|
34.8
x
|
35.5
x
|
40
x
|
27.6
x
|
21.3
x
|
13
x
|
9.56
x
|
8.21
x
|
Nbr of stocks (in thousands)
|
31,500
|
31,500
|
31,500
|
31,500
|
31,500
|
31,500
|
-
|
-
|
Reference price
2 |
1,437
|
1,562
|
2,077
|
2,355
|
2,422
|
2,413
|
2,413
|
2,413
|
Announcement Date
|
7/23/19
|
5/15/20
|
4/28/21
|
4/28/22
|
5/17/23
|
-
|
-
|
-
|
Fiscal Period: March |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
8,768
|
9,796
|
11,307
|
13,032
|
14,136
|
14,642
|
16,685
|
18,647
|
EBITDA
1 |
2,685
|
3,512
|
4,394
|
4,845
|
5,342
|
6,099
|
6,689
|
7,463
|
EBIT
1 |
2,592
|
3,380
|
4,232
|
4,627
|
5,138
|
5,776
|
6,372
|
7,274
|
Operating Margin
|
29.56%
|
34.5%
|
37.43%
|
35.51%
|
36.35%
|
39.45%
|
38.19%
|
39.01%
|
Earnings before Tax (EBT)
1 |
-
|
-
|
-
|
4,497
|
5,032
|
5,904
|
6,533
|
7,426
|
Net income
1 |
-
|
-
|
-
|
3,554
|
3,872
|
4,562
|
5,086
|
5,784
|
Net margin
|
-
|
-
|
-
|
27.27%
|
27.39%
|
31.15%
|
30.48%
|
31.02%
|
EPS
2 |
-
|
-
|
-
|
112.8
|
122.9
|
144.8
|
161.5
|
182.0
|
Free Cash Flow
1 |
2,640
|
2,693
|
3,063
|
3,292
|
4,877
|
2,952
|
4,530
|
5,313
|
FCF margin
|
30.11%
|
27.49%
|
27.09%
|
25.26%
|
34.5%
|
20.16%
|
27.15%
|
28.49%
|
FCF Conversion (EBITDA)
|
98.32%
|
76.67%
|
69.71%
|
67.94%
|
91.29%
|
48.39%
|
67.72%
|
71.19%
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
92.62%
|
125.93%
|
64.7%
|
89.06%
|
91.85%
|
Dividend per Share
2 |
65.00
|
95.00
|
90.00
|
80.00
|
75.00
|
80.30
|
133.2
|
180.4
|
Announcement Date
|
7/23/19
|
5/15/20
|
4/28/21
|
4/28/22
|
5/17/23
|
-
|
-
|
-
|
Fiscal Period: March |
2024 Q2
|
2024 S1
|
---|
Net sales
|
-
|
7,718
|
EBITDA
|
-
|
-
|
EBIT
1 |
1,572
|
-
|
Operating Margin
|
-
|
-
|
Earnings before Tax (EBT)
|
-
|
-
|
Net income
1 |
1,169
|
-
|
Net margin
|
-
|
-
|
EPS
|
-
|
-
|
Dividend per Share
|
-
|
-
|
Announcement Date
|
11/8/23
|
11/8/23
|
Fiscal Period: March |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
377
|
2,125
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
2,640
|
2,693
|
3,063
|
3,292
|
4,877
|
2,952
|
4,530
|
5,313
|
ROE (net income / shareholders' equity)
|
145%
|
197%
|
206%
|
164%
|
123%
|
99%
|
79.7%
|
89.3%
|
ROA (Net income/ Total Assets)
|
44.7%
|
55.2%
|
57.6%
|
55.3%
|
41.5%
|
36.7%
|
35.4%
|
40%
|
Assets
1 |
-
|
-
|
-
|
6,421
|
9,342
|
12,429
|
14,355
|
14,460
|
Book Value Per Share
2 |
41.30
|
44.10
|
52.00
|
85.40
|
114.0
|
186.0
|
252.0
|
294.0
|
Cash Flow per Share
2 |
-
|
-
|
-
|
-
|
-
|
185.0
|
187.0
|
224.0
|
Capex
1 |
88.8
|
320
|
-
|
314
|
518
|
401
|
438
|
493
|
Capex / Sales
|
1.01%
|
3.27%
|
-
|
2.41%
|
3.67%
|
2.74%
|
2.63%
|
2.64%
|
Announcement Date
|
7/23/19
|
5/15/20
|
4/28/21
|
4/28/22
|
5/17/23
|
-
|
-
|
-
|
Last Close Price
2,413
BDT Average target price
3,041
BDT Spread / Average Target +26.01% Consensus |
1st Jan change
|
Capi.
|
---|
| -1.93% | 692M | | +10.07% | 381B | | +14.18% | 74.67B | | -16.59% | 62.59B | | +0.82% | 52.86B | | -12.40% | 36.11B | | +3.54% | 33.57B | | +7.92% | 17.29B | | +6.30% | 14.75B | | -8.65% | 10.82B |
Other Personal Products
|